Skip to Main Content

Author Details

Sharon R Lewin
The University of Melbourne at the Peter Doherty Institute for Infection and Immunity
1993
373
69
Emma Lundberg (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36384811Pro-fibrogenic role of alarmin high mobility group box 1 in HIV-hepatitis B virus coinfection.AIDS2023
37753336Effect of high dose vitamin D<sub>3</sub> on the HIV-1 reservoir: A pilot randomised controlled trial.J Virus Erad2023
37515292Adaptation of Droplet Digital PCR-Based HIV Transcription Profiling to Digital PCR and Association of HIV Transcription and Total or Intact HIV DNA.Viruses2023
37744732Design and analysis considerations for early phase clinical trials in hepatitis B (HBV) cure research: the ACTG A5394 study in persons with both HIV and HBV.J Virus Erad2023
37652018Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice.Cell Rep Med2023
37493435Regional Analysis of Intact and Defective HIV Proviruses in the Brain of Viremic and Virally Suppressed People with HIV.Ann Neurol2023
37056754Soluble immune checkpoints as correlates for HIV persistence and T cell function in people with HIV on antiretroviral therapy.Front Immunol2023
37148585Broad immunity to SARS-CoV-2 variants of concern mediated by a SARS-CoV-2 receptor-binding domain protein vaccine.EBioMedicine2023
37440871Adaptation of the intact proviral DNA assay to a nanowell-based digital PCR platform.J Virus Erad2023
36541637Persistence of envelopes in different CD4+ T-cell subsets in antiretroviral therapy-suppressed people with HIV.AIDS2023
36842873Reducing time to new HIV diagnosis: time for change in the HIV diagnostic algorithm?Pathology2023
36776833Unequal distribution of genetically-intact HIV-1 proviruses in cells expressing the immune checkpoint markers PD-1 and/or CTLA-4.Front Immunol2023
36502576HIV DNA persists in hepatocytes in people with HIV-hepatitis B co-infection on antiretroviral therapy.EBioMedicine2023
34655216Cell-Associated Human Immunodeficiency Virus (HIV) Ribonucleic Acid Has a Circadian Cycle in Males With HIV on Antiretroviral Therapy.J Infect Dis2022
35573784Detection of Chimeric Cellular: HIV mRNAs Generated Through Aberrant Splicing in HIV-1 Latently Infected Resting CD4+ T Cells.Front Cell Infect Microbiol2022
35396591Antiretroviral Initiation at â¿¥800 CD4+ Cells/mm3 Associated With Lower Human Immunodeficiency Virus Reservoir Size.Clin Infect Dis2022
35817478Expanding the toolbox of HIV self-testing at home: the importance of user choice and feedback.Med J Aust2022
35778288Factors associated with weak positive SARS-CoV-2 diagnosis by reverse transcriptase-quantitative polymerase chain reaction (RT-qPCR).Pathology2022
36446447Lessons for the HIV response from structural innovations catalysed by COVID-19.BMJ Glob Health2022
36341446<i>IL7RA</i> single nucleotide polymorphisms are associated with the size and function of the MAIT cell population in treated HIV-1 infection.Front Immunol2022
36148896Shock and kill within the CNS: A promising HIV eradication approach?J Leukoc Biol2022
36040613Nafamostat Mesylate for Treatment of COVID-19 in Hospitalised Patients: A Structured, Narrative Review.Clin Pharmacokinet2022
35867351Intact HIV Proviruses Persist in the Brain Despite Viral Suppression with ART.Ann Neurol2022
36198308Memory CD4<sup>+</sup> T cells that co-express PD1 and CTLA4 have reduced response to activating stimuli facilitating HIV latency.Cell Rep Med2022
36029233The role of latency reversal in HIV cure strategies.J Med Primatol2022
35916523Markers of Immune Activation and Inflammation Are Associated with Higher Levels of Genetically-Intact HIV in HIV-HBV Co-Infected Individuals.J Virol2022
36282696Experimental Quantification of Interactions Between Drug Delivery Systems and Cells In Vitro: A Guide for Preclinical Nanomedicine Evaluation.J Vis Exp2022
35943163A Dynamic Interplay of Circulating Extracellular Vesicles and Galectin-1 Reprograms Viral Latency during HIV-1 Infection.mBio2022
35123267Immune checkpoint blockade in HIV.EBioMedicine2022
34853078Combination Immune Checkpoint Blockade Enhances IL-2 and CD107a Production from HIV-Specific T Cells Ex Vivo in People Living with HIV on Antiretroviral Therapy.J Immunol2022
35142755Nanoscale probing and imaging of HIV-1 RNA in cells with a chimeric LNA-DNA sensor.Nanoscale2022
35138683Mitigation strategies to safely conduct HIV treatment research in the context of COVID-19.J Int AIDS Soc2022
35080914Pembrolizumab induces HIV latency reversal in people living with HIV and cancer on antiretroviral therapy.Sci Transl Med2022
35104873Balancing Statistical Power and Risk in HIV Cure Clinical Trial Design.J Infect Dis2022
34863818Multiparameter immunohistochemistry analysis of HIV DNA, RNA and immune checkpoints in lymph node tissue.J Immunol Methods2022
34586085Neurotoxicity with high-dose disulfiram and vorinostat used for HIV latency reversal.AIDS2022
34781719A Possible Sterilizing Cure of HIV-1 Infection Without Stem Cell Transplantation.Ann Intern Med2022
30660173Circulating BAFF and CXCL10 levels predict response to pegylated interferon in patients with HBeAg-positive chronic hepatitis B.Asian Pac J Allergy Immunol2021
33600163<i>In Vivo</i> T Cell-Targeting Nanoparticle Drug Delivery Systems: Considerations for Rational Design.ACS Nano2021
33677480Impact of Anti-PD-1 and Anti-CTLA-4 on the Human Immunodeficiency Virus (HIV) Reservoir in People Living With HIV With Cancer on Antiretroviral Therapy: The AIDS Malignancy Consortium 095 Study.Clin Infect Dis2021
33647768Multiply spliced HIV RNA is a predictive measure of virus production ex vivo and in vivo following reversal of HIV latency.EBioMedicine2021
33564749Integrated immune dynamics define correlates of COVID-19 severity and antibody responses.Cell Rep Med2021
33640794A clinical trial of non-invasive imaging with an anti-HIV antibody labelled with copper-64 in people living with HIV and uninfected controls.EBioMedicine2021
33585037Interrupting antiretroviral therapy in HIV cure trials during COVID-19: Adaptation to low transmission settings.J Virus Erad2021
33859108The impact of immune checkpoint therapy on the latent reservoir in HIV-infected individuals with cancer on antiretroviral therapy.AIDS2021
34412859Longitudinal evaluation of laboratory-based serological assays for SARS-CoV-2 antibody detection.Pathology2021
34272399Consensus statement on the role of health systems in advancing the long-term well-being of people living with HIV.Nat Commun2021
33937887Multi-site assessment of rapid, point-of-care antigen testing for the diagnosis of SARS-CoV-2 infection in a low-prevalence setting: A validation and implementation study.Lancet Reg Health West Pac2021
34334614Viral, inflammatory, and reservoir characteristics of posttreatment controllers.Curr Opin HIV AIDS2021
34258311Evaluation of 6 Commercial SARS-CoV-2 Serology Assays Detecting Different Antibodies for Clinical Testing and Serosurveillance.Open Forum Infect Dis2021
  • 1 - 50 of 373

Recommended Authors

Alyssa R Martin
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 2015
Number of shared co-authors 5
Louise E Hogan
University of California San Francisco
Career Start Year 2012
Number of shared co-authors 13
Chi N Chan
Vaccine & Gene Therapy Institute, Oregon Health & Science University
Career Start Year 2010
Number of shared co-authors 4
George B Kyei
Noguchi Memorial Institute for Medical Research, University of Ghana
Career Start Year 2004
Number of shared co-authors 0
Satish K Pillai
Vitalant Research Institute, USA University of California san francisco
Career Start Year 2001
Number of shared co-authors 19
Davey M Smith
University of California San Diego
Career Start Year 2001
Number of shared co-authors 17
Sudhir Penugonda
Northwestern University Feinberg School of Medicine
Career Start Year 2000
Number of shared co-authors 3
Matthias Cavassini
Lausanne University Hospital, University of Lausanne
Career Start Year 1999
Number of shared co-authors 1
Carlo Torti
&quotMagna Graecia&quot University
Career Start Year 1998
Number of shared co-authors 4
Viviana Simon
Icahn School of Medicine at Mount Sinai
Career Start Year 1997
Number of shared co-authors 6
Laura Smeaton
Harvard TH Chan School of Public Health
Career Start Year 1996
Number of shared co-authors 6
Roger Paredes
Hospital Germans Trias i Pujol
Career Start Year 1992
Number of shared co-authors 10
Janet Andersen
Harvard School of Public Health
Career Start Year 1989
Number of shared co-authors 6
Jason Flamm
Sacramento Medical Center, Kaiser Permanente Northern California
Career Start Year 1988
Number of shared co-authors 2
Rafael Delgado
Instituto de Investigacion Hospital 12 de Octubre (imas12)
Career Start Year 1988
Number of shared co-authors 3
Carl J Fichtenbaum
University of Cincinnati
Career Start Year 1988
Number of shared co-authors 10
Ian Frank
IF School of Medicine, University of Pennsylvania
Career Start Year 1987
Number of shared co-authors 19
Susan Swindells
University of Nebraska Medical Center
Career Start Year 1987
Number of shared co-authors 5
Richard T Davey
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1985
Number of shared co-authors 9
Ann C Collier
University of Washington
Career Start Year 1984
Number of shared co-authors 10
Stephen Raffanti
Vanderbilt University Medical Center
Career Start Year 1983
Number of shared co-authors 1
Barbara Gripshover
Case Western Reserve University
Career Start Year 1981
Number of shared co-authors 3
Henry Clifford Lane
Division of Clinical Research, National Institutes of Allergy and Infectious Diseases
Career Start Year 1981
Number of shared co-authors 7
Michael S Saag
University of Alabama at Birmingham
Career Start Year 1980
Number of shared co-authors 17
Bonaventura Clotet
IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol
Career Start Year 1979
Number of shared co-authors 11
Amalio Telenti
Vir Biotechnology Inc.
Career Start Year 1977
Number of shared co-authors 10
Paul Volberding
Institute for Global Health Sciences, University of California san francisco
Career Start Year 1977
Number of shared co-authors 10
Dushyantha Jayaweera
University of Miami, Miller School of Medicine
Career Start Year 1977
Number of shared co-authors 4
Joseph B Margolick
Johns Hopkins Bloomberg School of Public Health
Career Start Year 1973
Number of shared co-authors 16
Luis J Montaner
Wistar Institute
Career Start Year 1958
Number of shared co-authors 16

Collaborators

Steven G Deeks
University of California san francisco
Co-authored papers 37
David A Cooper
Co-authored papers 19
Peter Bacchetti
University of California San Francisco
Co-authored papers 10
Rafick-Pierre Sekaly
Pathology Advanced Translational Research Unit, Emory University School of Medicine
Co-authored papers 9
Frederick M Hecht
Co-authored papers 9
Chloe L Thio
Johns Hopkins University
Co-authored papers 9
Patricia Price
Co-authored papers 6
Jacob D Estes
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Co-authored papers 6
Elizabeth Sinclair
Co-authored papers 5
Catherine L Cherry
University of Witwatersrand
Co-authored papers 5
Jeffrey D Lifson
Frederick National Laboratory
Co-authored papers 5
Benhur Lee
Icahn School of Medicine at Mount Sinai
Co-authored papers 5
Jeremy Sugarman
Johns Hopkins University, Berman Institute of Bioethics
Co-authored papers 5
Peter W Hunt
Co-authored papers 4
Martin Markowitz
Co-authored papers 4
Robert F Siliciano
Johns Hopkins University School of Medicine
Co-authored papers 4
Karey Cheong
Co-authored papers 4
Sulggi A Lee
Co-authored papers 4
Michael P Busch
Vitalant Research Institute
Co-authored papers 3
Namandjé N Bumpus
Co-authored papers 3
Vivek Naranbhai
Massachusetts General Hospital/Harvard Medical School
Co-authored papers 3
Christian Erikstrup
Co-authored papers 3
Sarah Fidler
Co-authored papers 3
Marc K Hellerstein
University of California berkeley
Co-authored papers 2
Jeffrey N Martin
Co-authored papers 2
Graeme J Stewart
Co-authored papers 2
Carl H June
University of Pennsylvania Department of Pathology & Laboratory Medicine
Co-authored papers 2
Eric Verdin
Buck Institute for Research on Aging
Co-authored papers 2
Paul A Ramsland
College of Science, RMIT University
Co-authored papers 2
Kenneth H Mayer
Co-authored papers 2
Release 1.2